Showing results (91-100 of 240) with videos related to

Sort By:
Pageof 24
Health Science Reports|July 29, 2026
Prevalence and Predictors of Substance Use Disorder Due to Gabapentinoids in Patients With Chronic Non-Cancer Pain: A Cross-Sectional StudyNeele Kufeld, Klaus Weckbecker, Eva Münster, et al.
Anesthesiology|January 31, 2002
Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidinePeter Kienbaum, Thorsten Heuter, Martin C Michel, et al.
Fortschritte Der Neurologie-Psychiatrie|June 12, 2024
[Acceptance by and evaluation of unidirectional hearing systems by patients in outpatient and (partial) inpatient geriatric psychiatric care]Barbara Leicher, Verena Caroline Buschert, Monia Belkahia, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|March 11, 2026
[Regional characteristics of diagnoses of unemployed people under socio-medical assessments by the Medical Service of the Federal Employment Agency]Andreas Guenter Franke, Norbert Scherbaum, Kirsi Marjaana Manz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2005
History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled studyEugen Davids, Ulla von Bünau, Michael Specka, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 26, 2015
Natural prevalence of resistance-associated variants in hepatitis C virus NS5A in genotype 3a-infected people who inject drugs in GermanyAndreas Walker, Holger Siemann, Svenja Groten, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 17, 2021
Opioid painkiller dependence in a sample of elderly medical inpatientsStefania Chiappini, Fabrizio Schifano, Giovanni Martinotti, et al.
BMC Infectious Diseases|May 21, 2005
Prevalence and risk factors of syphilis infection among drug addictsNorbert Scherbaum, Bernhard T Baune, Rafael Mikolajczyk, et al.
Frontiers in Psychiatry|December 21, 2020
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?Benedikt Bernd Claus, Michael Specka, Heath McAnally, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 19, 2009
An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocolUdo Bonnet, Reza Hamzavi-Abedi, Michael Specka, et al.
Pageof 24